Zealand Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Zealand Pharma has a total shareholder equity of DKK2.8B and total debt of DKK272.6M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are DKK3.6B and DKK748.8M respectively.
Key information
9.6%
Debt to equity ratio
DKK 272.60m
Debt
Interest coverage ratio | n/a |
Cash | DKK 3.23b |
Equity | DKK 2.84b |
Total liabilities | DKK 748.84m |
Total assets | DKK 3.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ZEALC's short term assets (DKK3.4B) exceed its short term liabilities (DKK275.6M).
Long Term Liabilities: ZEALC's short term assets (DKK3.4B) exceed its long term liabilities (DKK473.3M).
Debt to Equity History and Analysis
Debt Level: ZEALC has more cash than its total debt.
Reducing Debt: ZEALC's debt to equity ratio has increased from 0% to 9.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZEALC has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ZEALC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.